Portal:AOP/FeaturedPathways
From WikiPathways
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | {| style="margin: 10px" | |
| - | + | |width=100px; cell padding=50px|{{#pwImage:Pathway:WP3997|250px||Epilepsy Adverse Outcome Pathway (Homo sapiens)}} | |
| - | + | |width=100px|{{#pwImage:Pathway:WP3980|250px||Protein alkylation leading to liver fibrosis (Homo sapiens)}} | |
| - | + | |width=100px|{{#pwImage:Pathway:WP3624|250px||Lung fibrosis (Homo sapiens)}} | |
| - | + | |width=100px|{{#pwImage:Pathway:WP3632|250px||Lung fibrosis (Mus musculus)}} | |
| - | + | |- | |
| - | + | |width=100px|{{#pwImage:Pathway:WP4010|250px||Liver steatosis AOP (Homo sapiens)}} | |
| - | + | |width=100px|{{#pwImage:Pathway:WP4011|250px||Steatosis AOP (Homo sapiens)}} | |
| - | + | |width=100px|{{#pwImage:Pathway:WP4017|250px||Selective serotonin reuptake inhibitors lead to several adverse outcomes (Homo sapiens)}} | |
| - | + | |width=100px|{{#pwImage:Pathway:WP4026|250px||Gastric ulcer formation (Homo sapiens)}} | |
| - | + | |- | |
| - | + | |width=100px|{{#pwImage:Pathway:WP2643|250px||Nanoparticle-mediated activation of receptor signaling (Homo sapiens)}} | |
| - | + | |width=100px|{{#pwImage:Pathway:WP2507|250px||Nanomaterial induced apoptosis (Homo sapiens)}} | |
| - | + | |width=100px|{{#pwImage:Pathway:WP2513|250px||Nanoparticle triggered regulated necrosis (Homo sapiens)}} | |
| - | + | |width=100px|{{#pwImage:Pathway:WP2509|250px||Nanoparticle triggered autophagic cell death (Homo sapiens)}} | |
| + | |- | ||
| + | |width=100px|{{#pwImage:Pathway:WP3287|250px||Overview of nanoparticle effects (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP3890|250px||Nanomaterial induced inflammasome activation (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP3181|250px||Nanoparticle-mediated activation of receptor signaling (Bos taurus)}} | ||
| + | |} | ||
Revision as of 19:08, 4 April 2018
|
Image does not exist Epilepsy Adverse Outcome Pathway (Homo sapiens) |
Image does not exist Protein alkylation leading to liver fibrosis (Homo sapiens) |
Image does not exist Lung fibrosis (Homo sapiens) |
Image does not exist Lung fibrosis (Mus musculus) |
|
Image does not exist Liver steatosis AOP (Homo sapiens) |
Image does not exist Steatosis AOP (Homo sapiens) |
Image does not exist Selective serotonin reuptake inhibitors lead to several adverse outcomes (Homo sapiens) |
Image does not exist Gastric ulcer formation (Homo sapiens) |
|
Image does not exist Nanoparticle-mediated activation of receptor signaling (Homo sapiens) |
Image does not exist Nanomaterial induced apoptosis (Homo sapiens) |
Image does not exist Nanoparticle triggered regulated necrosis (Homo sapiens) |
Image does not exist Nanoparticle triggered autophagic cell death (Homo sapiens) |
|
Image does not exist Overview of nanoparticle effects (Homo sapiens) |
Image does not exist Nanomaterial induced inflammasome activation (Homo sapiens) |
Image does not exist Nanoparticle-mediated activation of receptor signaling (Bos taurus) |
